Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-25-000162

CEO sold 5,603 shares at $2.15 ($12,064)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

O'Neill Gilmore Neil · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-03 Sale : show line 1 in the form 10b5-1 −5,603 $2.15 $12,064 269,087 D
Open-market sales · 5,603 sh · avg $2.15 · $12,064
Loading xslF345X05/wk-form4_1764884318.xml…